We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current TTIPF market cap is 23.93M. The company's latest EPS is CAD -0.1094 and P/E is -6.67.
| Year End 31 December 2023 | 2021 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 0 | -1.39M | -3k | -3.61M | -4.72M |
| Net Income | -93k | -1.22M | -224k | -3.92M | -5.03M |
| Year End 31 December 2023 | 2021 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 146k | 231k | 3.43M | 6.29M | 7.24M |
| Total Liabilities | 63k | 1.29M | 3.49M | 307k | 1.71M |
| Total Equity | 83k | -1.06M | -61k | 5.98M | 5.53M |
| Year End 31 December 2023 | 2021 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -36k | -768k | -67k | -2.09M | -3.25M |
| Investing | N/A | N/A | N/A | 107k | N/A |
| Financing | N/A | 819k | 3.33M | 8.13M | 4.12M |
| Market Cap | 23.93M |
| Price to Earnings Ratio | -6.67 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.75 |
| Price to Book Ratio | 6.07 |
| Dividend Yield | - |
| Shares Outstanding | 46.02M |
| Average Volume (1 week) | 1,000 |
| Average Volume (1 Month) | 1.5k |
| 52 Week Change | 25.30% |
| 52 Week High | 0.52 |
| 52 Week Low | 0.415 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Thiogenesis Therapeutics Corporation (PK) |
| Address |
4 king street west, ste. 401 toronto, ontario M5H 1B6 |
| Website | https://www.thiogenesis.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
